|
Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
RECRUITINGSponsored by Centre Médical Porte Verte
Actively Recruiting
SponsorCentre Médical Porte Verte
Started2023-09-30
Est. completion2024-10-30
Eligibility
Age18 Years – 65 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06042972
Summary
This observational study aims to estimate the prevalence of women from 1 to 4 years postpartum in Yvelines, who are suspected to suffer from postpartum depression, using the Edinburg Post natal Depression Scale (EPDS) and the Patient Heath Questionnaire 2 (PHQ2) and evaluate the factors that could be linked to it.
Eligibility
Age: 18 Years – 65 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * Women over 18 years old * Women from 1 year to 4 years postpartum or having children aged from 1 to 4 years old * Patient gave their consent to participate in the study * Patient lives in Yvelines * Patient speaks and understands French * Patient reads and writes in French Exclusion Criteria: * Patient suffered from postpartum depression in the 1st year after giving birth or is currently being treated for postpartum depression that started showing symptoms in the 1st year after giving birth. * Patient is currently pregnant * Patient gave birth less than 1 year prior or more than 4 years prior; or has a child who is less than one year old; or 5 or more years old * Patient didn't give her consent to participate in the study * Patient is under guardianship or judicial safeguard
Conditions2
DepressionPost Partum Depression
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorCentre Médical Porte Verte
Started2023-09-30
Est. completion2024-10-30
Eligibility
Age18 Years – 65 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06042972